Can a phone app help lower your cholesterol? new study aims to find out

NCT ID NCT07478887

Recruiting now Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital health program called Corrie Lipids in about 1,000 adults with high LDL cholesterol and heart disease risk. The program includes a smartphone app for tracking cholesterol, medication reminders, and education, plus training for doctors to improve cholesterol management. Researchers want to see if the program helps more people reach their LDL cholesterol goals and if it's practical to use in real clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Corrie Lipids Digital Health Program (smartphone app and clinician education)
What this could lead to: If successful, this program could offer a practical, scalable way to help more people manage their cholesterol and reduce heart disease risk.
What could go wrong: This is an early-stage implementation study, not a drug trial. Success depends on people actually using the app and clinicians adopting it, which may not happen consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerotic cardiovascular disease diabetes mellitus familial hypercholesterolemia hyperlipidemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR RISK DIGITAL HEALTH IMPLEMENTATION SCIENCE LDL-C LIPIDS

Contacts and locations

Locations

Johns Hopkins University School of Medicine
RECRUITING

Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.